Healthcare

Percheron Therapeutics Redirects Focus After Trial Results

Highlights,Percheron Therapeutics focuses on rebuilding after clinical trial outcomes.,The company explores diversification and pipeline expansion str...

Imugene Doses First Australian Patient in Phase 1b Azer-Cel Clinical...

Highlights:,Imugene (ASX:IMU) has commenced its Phase 1b clinical trial for azer-cel at Royal Prince Alfred Hospital in Sydney, marking a significant...

LTR Pharma secures national distribution agreement for its ED treatm...

Highlights:,Symbion to distribute Spontan, an innovative nasal spray for erectile dysfunction, across its extensive pharmacy network.,Collaboration su...

The Expanding Potential of GLP-1 Drugs: A Transformative Medical Rev...

Highlight:,GLP-1 receptor agonists, like Ozempic and Wegovy, initially developed for diabetes and obesity, are now showing promise in treating a range...

Labor Plans Major Health Policy Overhaul Ahead of Federal Election

Highlights:,Labor intends to expand bulk billing, increase urgent care clinics, and reform GP subsidies under Medicare to alleviate healthcare costs.,...

Proteomics International’s OxiDx Test Demonstrates Breakthrough in M...

Highlights,OxiDx test shows potential to identify muscle damage and assess recovery in elite marathon runners.,Study highlights the need for personali...

Advances in Biopharma: Kidney Imaging, Therapies, and Diagnostics

Highlights,Telix Pharmaceuticals (TLX) is advancing its kidney cancer imaging agent for potential US approval.,Dimerix (DXB) achieves a milestone in r...

Imricor Medical Expands into Middle East with First Sales in Qatar,...

Highlights:,Imricor has secured its first purchase order for MRI-guided ablation equipment in Qatar.,The company is working with exclusive distributor...

Proteomics International Shares Surge Nearly 20% on Monday. Here's W...

Highlights,Proteomics International Laboratories unveils PromarkerEndo blood test, capable of diagnosing all stages of endometriosis with high accurac...

Goodman Group Surges Over 45% in 2024, Fueled by AI-Driven Data Cent...

Highlights,Goodman Group's stock rises over 45% in 2024, its best performance since 2006.,Data centres now make up 42% of Goodman’s AU$12.8 billion de...

Pro Medicus Scores Fourth Major Contract in a Month, Shares Edge Hig...

Highlights,Pro Medicus secures a $15 million, five-year contract with Duke University Health System.,This marks the company’s fourth significant deal...

Pro Medicus (ASX:PME) Expands North American Reach with Duke Univers...

Highlights,- Pro Medicus (PME) secures a $15 million deal with Duke University Health System.,- The agreement extends Pro Medicus’ cloud-based imaging...

ASX Small Caps to Watch: Undervalued Stocks With Insider Confidence...

Highlights:,Resilient Market Amid Challenges,: The ASX 200 showed a modest gain of 0.29% in December 2024, despite lingering inflation concerns. Small...

AVITA Medical Secures FDA Approval for RECELL GO® Mini, Expanding Tr...

Highlights:,FDA Approval:,RECELL GO Mini, designed for smaller wounds, enhances the functionality of the RECELL GO platform.,Optimized Design:,The car...

Avita Medical's Spray-On Skin Device Earns FDA Approval

Highlights,- Avita Medical (AVH) receives FDA approval for RECELL GO Mini, expanding its advanced wound care solutions.,- The new Mini GO device targe...

Imugene Secures Major Capital Boost to Advance Clinical Trials

Highlights,- Imugene extends cash runway to late 2025 through strategic capital injection.,- Funding supports clinical trials for key programs, includ...

Polynovo's Record Sales Drive ASX Momentum Amid Market Recovery

Highlights:,Polynovo,(PNV) surged on record-breaking monthly sales.,ASX recovered from last week’s technical disruptions to open on time.,Real Estate,...

PolyNovo Achieves Record $10.1M Monthly Sales in November 2024

Highlights,Record Monthly Sales:,PolyNovo reported,$10.1M,in unaudited sales for November 2024, marking the company's highest monthly performance to d...

Rhythm Biosciences Acquires Genetype Business from Genetic Technolog...

Highlights,Strategic Acquisition:,Rhythm Biosciences has entered into an Asset Sale Agreement (ASA) with the administrators of Genetic Technologies Lt...

Prescient Therapeutics Shares Surge 24% on FDA Approval for PTX-100...

Highlights,FDA Clears Phase 2 IND:,The U.S. FDA has approved Prescient Therapeutics' Investigational New Drug (IND) application for its Ras pathway in...